查看购物车
  • Traditional Chinese
  • English
  • Japanese
亚太蛋白质体学市场（按产品、应用和国家划分）分析与预测（2024 年至 2034 年）
市场调查报告书
商品编码
1743358

亚太蛋白质体学市场（按产品、应用和国家划分）分析与预测（2024 年至 2034 年）

Asia-Pacific Proteomics Market: Focus on Offerings, Application, and Country - Analysis and Forecast, 2024-2034
出版日期: | 出版商: BIS Research | 英文 81 Pages | 商品交期: 1-5个工作天内

价格

亚太蛋白质体学市场规模预计将从 2024 年的 69.5 亿美元增至 2034 年的 257.8 亿美元，2024-2034 年预测期间的复合年增长率为 14.01%。

亚太地区的蛋白质体学产业正在迅速扩张，这得益于提供高度精确的蛋白质分析和质谱分析的下一代定序技术的发展，部分原因是人们对个人化医疗的日益重视，这导致了新生物标誌物的发现和疾病分析工具的改进。

透过不断扩大官民合作关係以及医院、生物技术公司和学术机构之间的合作，新的蛋白质组学应用正在更快地发展，亚太地区各国政府也正在透过国家资金筹措计画鼓励研发和创新。此外，该地区人口老化加剧和慢性病盛行率上升，迫切需要更先进的诊断设备和早期检测技术。

主要市场统计数据
预测期 2024-2034
2024年评估 69.5亿美元
2034年的预测 257.8亿美元
复合年增长率 14.01%

随着亚太地区继续投资生命科学并加强其临床研究基础设施，蛋白质体学正在成为推动全部区域精准医疗和医疗保健创新的重要支柱。

蛋白质体学是亚太地区生命科学生物技术领域潜力市场。随着质谱、次世代定序(NGS) 和生物资讯学等分析技术的发展，蛋白质体学解决方案在全部区域的研究、诊断和药物开发应用中的应用日益广泛。医疗保健支出的增加、慢性病发病率的上升以及个人化治疗的趋势，推动了临床和转化研究对更深入的蛋白质水平洞察的需求。

中国、印度、日本、韩国和新加坡等国政府正透过国家研发计画、基础建设和财政项目推动蛋白质体学的发展。生技公司、学术机构和医疗保健机构之间的官民合作关係也推动着蛋白质体学技术和平台的创新。此外，人工智慧和机器学习在蛋白质数据处理中的日益融合，正在提高准确性、速度和可扩展性。

儘管取得了这些进展，但诸如技术成本高昂、合格人才短缺以及欠低度开发国家难以获得尖端研究设施等挑战仍然存在。然而，随着精准医疗领域的兴趣和资金持续增长，亚太地区蛋白质组学市场预计将稳步增长，并在全部区域诊断和治疗方法的变革中发挥关键作用。

市场区隔

细分 1：按产品

  • 产品
  • 服务

细分2：按应用

  • 药物研发
  • 临床诊断
  • 其他的

细分3：按地区

  • 亚太地区
    • 中国
    • 日本
    • 印度
    • 韩国
    • 澳洲
    • 其他的

亚太蛋白质体学市场趋势、驱动因素与挑战

趋势

  • 质谱和次世代定序等高通量技术的采用日益增多
  • 个人化医疗和精准医疗日益受到关注
  • 拓展蛋白质体学在疾病诊断、药物开发和生物标记发现的应用
  • 扩大产学合作与公私合作研究伙伴关係
  • 人工智慧与生物资讯学在蛋白质体学数据分析中的整合

驱动程式

  • 政府透过国家研发计划和医疗现代化计划提供支持
  • 生物技术和製药公司加大对蛋白质体学研究的投资
  • 慢性病增加和人口老化推动早期检测需求
  • 亚太新兴国家医疗支出增加、基础建设改善
  • 该地区临床试验和转化研究快速成长

任务

  • 蛋白质体学仪器和数据分析平台高成本
  • 中低收入国家取得先进技术的机会有限
  • 缺乏熟练的专业人员和生物资讯学专家
  • 复杂的数据解释和标准化问题
  • 关于患者数据使用和生物标记检验的监管和伦理问题

产品/创新策略：亚太蛋白质体学市场已根据产品、应用、国家等不同类别进行了广泛细分。这有助于读者清楚概况哪个细分市场占有最大份额以及哪个细分市场在未来几年可能会成长。

竞争策略：亚太蛋白质体学市场拥有许多拥有丰富产品和服务组合的现有企业。本研究分析和概述的亚太蛋白质体学市场主要企业包括提供蛋白质体学产品和服务的现有企业。

本报告研究了亚太蛋白质组学市场，并概述了市场、产品、应用和国家趋势以及参与市场的公司概况。

目录

执行摘要

第一章 市场

  • 市场展望
  • 主要发现
  • 亚太蛋白质体学市场概况
  • 产业展望
  • 趋势：现况与未来影响评估
  • 专利分析
  • 法律规范
  • 产品基准
  • 市场动态概览

2. 蛋白质体学市场（按地区划分），百万美元，2022 年至 2034 年

  • 区域摘要
  • 亚太地区
    • 区域概况
    • 市场成长动力
    • 成长抑制因素
    • 亚太蛋白质体学市场（按应用）
    • 亚太蛋白质体学市场（按产品提供）
    • 中国
    • 印度
    • 澳洲
    • 日本
    • 韩国
    • 其他的

第三章 市场竞争基准化分析与公司概况

  • 蛋白质体学市场：竞争格局
    • 企业策略 2022 年 1 月 - 2024 年 12 月
  • 公司简介
    • Takara Bio Inc.

第四章调查方法

Product Code: BHP2992SS

Introduction to Asia-Pacific Proteomics Market

The Asia-Pacific proteomics market is projected to reach $25.78 billion by 2034 from $6.95 billion in 2024, growing at a CAGR of 14.01% during the forecast period 2024-2034. The Asia-Pacific (APAC) proteomics industry is expanding rapidly due to developments in next-generation sequencing technologies that provide high-precision protein analysis and mass spectrometry. The growing emphasis on individualised healthcare, together with increased attempts to find new biomarkers and improve disease profiling tools, is another factor contributing to this trend.

New proteomic applications are being developed more quickly thanks to expanding public-private partnerships and cooperation between hospitals, biotech companies, and academic institutions, while governments around APAC are promoting research and innovation through national financing programs. Furthermore, there is an urgent need for better diagnostic instruments and early detection techniques due to the region's growing senior population and the increase in the prevalence of chronic illnesses.

KEY MARKET STATISTICS
Forecast Period2024 - 2034
2024 Evaluation$6.95 Billion
2034 Forecast$25.78 Billion
CAGR14.01%

Proteomics is emerging as a key pillar in promoting precision medicine and healthcare innovation across the region as APAC keeps investing in life sciences and fortifying its clinical research infrastructure.

Market Introduction

Proteomics is a fast developing, high-potential market in the life sciences and biotechnology sector in Asia-Pacific (APAC). Proteomic solutions are increasingly being used in research, diagnostics, and drug development applications throughout the region, driven by developments in analytical technologies including mass spectrometry, next-generation sequencing (NGS), and bioinformatics. The need for more in-depth protein-level insights in clinical and translational research is being fuelled by rising healthcare expenditures, the incidence of chronic diseases, and the trend towards personalised therapy.

Governments in China, India, Japan, South Korea, and Singapore promote proteomics through national R&D initiatives, infrastructure development, and financial programs. Innovation in proteomics techniques and platforms is also being accelerated by public-private partnerships among biotech companies, academic institutions, and healthcare providers. Furthermore, accuracy, speed, and scalability are being improved by the increasing integration of AI and machine learning in protein data processing.

Notwithstanding these developments, issues including exorbitant technological costs, a shortage of qualified personnel, and restricted access to cutting-edge research facilities in underdeveloped countries continue to exist. But as interest in and funding for precision healthcare continue to rise, the APAC proteomics market is expected to grow steadily and play a significant part in changing diagnostic and treatment approaches throughout the area.

Market Segmentation:

Segmentation 1: by Offering

  • Product
  • Service

Segmentation 2: by Application

  • Drug Discovery
  • Clinical Diagnostics
  • Others

Segmentation 3: by Region

  • Asia-Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Rest-of-Asia-Pacific

APAC Proteomics Market Trends, Drivers and Challenges

Trends

  • Increasing adoption of high-throughput technologies like mass spectrometry and next-generation sequencing
  • Rising focus on personalized medicine and precision healthcare
  • Expansion of proteomic applications in disease diagnostics, drug development, and biomarker discovery
  • Growth in academic-industry collaborations and public-private research partnerships
  • Integration of AI and bioinformatics in proteomic data analysis

Drivers

  • Government support through national R&D programs and healthcare modernization initiatives
  • Growing investment by biotech and pharmaceutical companies in proteomic research
  • Rising prevalence of chronic diseases and aging population driving demand for early detection
  • Increased healthcare spending and improved infrastructure across emerging APAC economies
  • Surge in clinical trials and translational research efforts in the region

Challenges

  • High cost of proteomics instruments and data analysis platforms
  • Limited access to advanced technologies in low- and middle-income countries
  • Shortage of skilled professionals and bioinformatics expertise
  • Complex data interpretation and standardization issues
  • Regulatory and ethical concerns around patient data use and biomarker validation

How can this report add value to an organization?

Product/Innovation Strategy: The Asia-Pacific proteomics market has been extensively segmented based on various categories, such as offering, application, and country. This can help readers get a clear overview of which segments account for the largest share and which ones are well-positioned to grow in the coming years.

Competitive Strategy: The Asia-Pacific proteomics market has numerous established players with product and service portfolios. Key players in the Asia-Pacific proteomics market analyzed and profiled in the study involve established players offering proteomics products and services.

Table of Contents

Executive Summary

Scope and Definition

1 Market

  • 1.1 Market Outlook
    • 1.1.1 Comparative Advantages and Disadvantages of Proteomics Over Other Omics
    • 1.1.2 Proteomics Techniques by Introduction with Principles and Advantages/Limitations
  • 1.2 Key Findings
  • 1.3 Asia-Pacific Proteomics Market Scenario
    • 1.3.1 Realistic Scenario
    • 1.3.2 Optimistic Scenario
    • 1.3.3 Pessimistic Scenario
  • 1.4 Industry Outlook
    • 1.4.1 Supply Chain Overview
  • 1.5 Trends: Current and Future Impact Assessment
    • 1.5.1 Increasing Automation for End-to-End Proteomics Workflow
    • 1.5.2 Significant Number of Collaborations among Market Players
    • 1.5.3 Growing Proteomics Research to Identify Disease Biomarkers
  • 1.6 Patent Analysis
    • 1.6.1 Patent Filing Trend (by Country, Year)
  • 1.7 Regulatory Framework
    • 1.7.1 Japan
      • 1.7.1.1 Regulatory Requirements for Proteomics Products Intended as Medical Devices
      • 1.7.1.2 Regulatory Requirements for Clinical Proteomics Labs in Japan
    • 1.7.2 China
      • 1.7.2.1 Regulatory Requirements for Proteomics Products Intended as Medical Devices
  • 1.8 Product Benchmarking
  • 1.9 Market Dynamics Overview
    • 1.9.1 Market Drivers
      • 1.9.1.1 Increasing Prevalence of Chronic Diseases
      • 1.9.1.2 Increasing Technological Advancements
      • 1.9.1.3 Advancements in Personalized Medicine and Drug Discovery
    • 1.9.2 Market Restraints
      • 1.9.2.1 Shortage of Skilled Professionals
      • 1.9.2.2 Complexity in Analyzing Data of Proteomics Research
    • 1.9.3 Market Opportunities
      • 1.9.3.1 Progress in Nanoproteomics Platforms to Enhance and Thoroughly Analyze Natural Protein Complexes

2 Proteomics Market (by Region), $Million, 2022-2034

  • 2.1 Regional Summary
  • 2.2 Asia-Pacific
    • 2.2.1 Regional Overview
    • 2.2.2 Driving Factors for Market Growth
    • 2.2.3 Factors Challenging the Market
    • 2.2.4 Asia-Pacific Proteomics Market, by Application
    • 2.2.5 Asia-Pacific Proteomics Market, by Offering
      • 2.2.5.1 Asia-Pacific Proteomics Market, by Product
    • 2.2.6 China
      • 2.2.6.1 China Proteomics Market, by Application
      • 2.2.6.2 China Proteomics Market, by Offering
        • 2.2.6.2.1 China Proteomics Market, by Product
    • 2.2.7 India
      • 2.2.7.1 India Proteomics Market, by Application
      • 2.2.7.2 India Proteomics Market, by Offering
        • 2.2.7.2.1 India Proteomics Market, by Product
    • 2.2.8 Australia
      • 2.2.8.1 Australia Proteomics Market, by Application
      • 2.2.8.2 Australia Proteomics Market, by Offering
        • 2.2.8.2.1 Australia Proteomics Market, by Product
    • 2.2.9 Japan
      • 2.2.9.1 Japan Proteomics Market, by Application
      • 2.2.9.2 Japan Proteomics Market, by Offering
        • 2.2.9.2.1 Japan Proteomics Market, by Product
    • 2.2.10 South Korea
      • 2.2.10.1 South Korea Proteomics Market, by Application
      • 2.2.10.2 South Korea Proteomics Market, by Offering
        • 2.2.10.2.1 South Korea Proteomics Market, by Product
    • 2.2.11 Rest-of-Asia-Pacific
      • 2.2.11.1 Rest-of-Asia-Pacific Proteomics Market, by Application
      • 2.2.11.2 Rest-of-Asia-Pacific Proteomics Market, by Offering
        • 2.2.11.2.1 Rest-of-Asia-Pacific Proteomics Market, by Product

3 Markets - Competitive Benchmarking & Company Profiles

  • 3.1 Proteomics Market: Competitive Landscape
    • 3.1.1 Corporate Strategies, January 2022-December 2024
  • 3.2 Company Profiles
    • 3.2.1 Takara Bio Inc.
      • 3.2.1.1 Overview
      • 3.2.1.2 Top Products/ Services
      • 3.2.1.3 Top Competitors
      • 3.2.1.4 Target Customers
      • 3.2.1.5 Key Personnel
      • 3.2.1.6 Analyst View

4 Research Methodology

  • 4.1 Data Sources
    • 4.1.1 Primary Data Sources
    • 4.1.2 Secondary Data Sources
    • 4.1.3 Data Triangulation
  • 4.2 Market Estimation and Forecast

List of Figures

  • Figure 1: Asia-Pacific Proteomics Market (by Application), $Billion, 2022, 2027, and 2034
  • Figure 2: Asia-Pacific Proteomics Market (by Product), $Billion, 2022, 2027, and 2034
  • Figure 3: Key Events to Keep Track of within the Proteomics Market
  • Figure 4: Asia-Pacific Proteomics Market Size, $Billion, 2022-2034
  • Figure 5: Proteomics Literature Published (January 2015 to December 2024)
  • Figure 6: Asia-Pacific Proteomics Market Size and Growth Potential (Realistic Scenario), $Billion, 2022-2034
  • Figure 7: Asia-Pacific Proteomics Market Size and Growth Potential (Optimistic Scenario), $Billion, 2022 to 2034
  • Figure 8: Asia-Pacific Proteomics Market Size and Growth Potential (Pessimistic Scenario), $Billion, 2022 to 2034
  • Figure 9: Supply Chain and Risks within the Supply Chain
  • Figure 10: Key Features of End-to-End Proteomics Workflow
  • Figure 11: Proteomics Market, Patent Analysis (by Country), January 2021-December 2024
  • Figure 12: Proteomics Market, Patent Analysis (by Year), January 2021-December 2024
  • Figure 13: Proteomics Market, Product Benchmarking (by Product)
  • Figure 14: Impact Analysis of Market Navigating Factors, 2024-2034
  • Figure 15: Timeline on the Personalized Medicine Journey of Protein
  • Figure 16: Difficulties Faced in Top-Down Proteomics
  • Figure 17: Future Outlook of Nanoproteomics
  • Figure 18: Asia-Pacific Proteomics Market, $Billion, 2022-2034
  • Figure 19: Proteomics Literature Published in China (January 2015 to December 2024)
  • Figure 20: China Proteomics Market, $Billion, 2022-2034
  • Figure 21: Proteomics Literature Published in India (January 2015 to December 2024)
  • Figure 22: India Proteomics Market, $Billion, 2022-2034
  • Figure 23: Proteomics Literature Published in Australia (January 2015 to December 2024)
  • Figure 24: Australia Proteomics Market, $Billion, 2022-2034
  • Figure 25: Proteomics Literature Published in Japan (January 2015 to December 2024)
  • Figure 26: Japan Proteomics Market, $Billion, 2022-2034
  • Figure 27: Proteomics Literature Published in South Korea (January 2015 to December 2024)
  • Figure 28: South Korea Proteomics Market, $Billion, 2022-2034
  • Figure 29: Rest-of-Asia-Pacific Proteomics Market, $Billion, 2022-2034
  • Figure 30: Corporate Strategies, January 2022-December 2024
  • Figure 31: Data Triangulation
  • Figure 32: Top-Down and Bottom-Up Approach
  • Figure 33: Assumptions and Limitations

List of Tables

  • Table 1: Market Snapshot
  • Table 2: Opportunities across Regions
  • Table 3: The Diversified Exposure of Proteomics
  • Table 4: Comparative Analysis of Proteomics: Advantages and Disadvantages Over Other Omics Approaches
  • Table 5: Introduction to Proteomics Techniques: Principles, Advantages, and Limitations
  • Table 6: Comparison of Existing and Emerging Paradigms in Proteomics Technologies
  • Table 7: Proteomics Market Trend Analysis
  • Table 8: Some of the Partnerships and Collaborations in the Proteomics Market
  • Table 9: List of Molecular Targets Identified with Proteomics
  • Table 10: Cancer Cases Expected Between 2020 and 2040
  • Table 11: Proteomics Market, Regulatory Approvals, and New Offerings
  • Table 12: Cancer Biomarkers Discovered by Proteomics and its Applications in Personalized Medicine
  • Table 13: Proteomics Market (by Region), $Billion, 2022-2034
  • Table 14: Asia-Pacific Proteomics Market (by Application), $Billion, 2022-2034
  • Table 15: Asia-Pacific Proteomics Market (by Offering), $Billion, 2022-2034
  • Table 16: Asia-Pacific Proteomics Market (by Product), $Billion, 2022-2034
  • Table 17: China Proteomics Market (by Application), $Billion, 2022-2034
  • Table 18: China Proteomics Market (by Offering), $Billion, 2022-2034
  • Table 19: China Proteomics Market (by Product), $Billion, 2022-2034
  • Table 20: India Proteomics Market (by Application), $Billion, 2022-2034
  • Table 21: India Proteomics Market (by Offering), $Billion, 2022-2034
  • Table 22: India Proteomics Market (by Product), $Billion, 2022-2034
  • Table 23: Australia Proteomics Market (by Application), $Billion, 2022-2034
  • Table 24: Australia Proteomics Market (by Offering), $Billion, 2022-2034
  • Table 25: Australia Proteomics Market (by Product), $Billion, 2022-2034
  • Table 26: Japan Proteomics Market (by Application), $Billion, 2022-2034
  • Table 27: Japan Proteomics Market (by Offering), $Billion, 2022-2034
  • Table 28: Japan Proteomics Market (by Product), $Billion, 2022-2034
  • Table 29: South Korea Proteomics Market (by Application), $Billion, 2022-2034
  • Table 30: South Korea Proteomics Market (by Offering), $Billion, 2022-2034
  • Table 31: South Korea Proteomics Market (by Product), $Billion, 2022-2034
  • Table 32: Rest-of-Asia-Pacific Proteomics Market (by Application), $Billion, 2022-2034
  • Table 33: Rest-of-Asia-Pacific Proteomics Market (by Offering), $Billion, 2022-2034
  • Table 34: Rest-of-Asia-Pacific Proteomics Market (by Product), $Billion, 2022-2034